patent/PA-8504401-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PA-8504401-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
filingDate	2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8945c6552722b29811feab7cef9156e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c19d92267121ebd976adca21627d111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf8f152f1318a08e556bc782259fc330 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2b65347af73cc62d4038ba5a6c1fd02
publicationDate	2002-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PA-8504401-A1
titleOfInvention	PHARMACEUTICALLY ACTIVE COMPOUNDS
abstract	FORMULA I COMPOUNDS ARE PROVIDED: IN WHICH R1, R2, R3, R4, AND X HAVE THE MEANINGS GIVEN IN THE DESCRIPTIVE MEMORY, WHICH ARE USEFUL FOR THE HEALING AND PROFILACTIC TREATMENT OF A MEDICAL DISORDER FOR WHICH THE INHIBITION OF A GUANOSIN 3 '5' - PHOSPHODESTERASE CYCLIC MONOPHOSPHATE (FOR EXAMPLE cGMP PDE5).
priorityDate	1999-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527025 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398635 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507980

Total number of triples: 33.